Tag: tamoxifenTreatment
Tamoxifen treatment: Factors related to tamoxifen treatment. Tamoxifen is prescribed for both premenopausal and postmenopausal women with estrogen receptor positive (ER+) breast cancer or at high risk for it.
Articles
News
- 06/30/20
- Failure to adhere to tamoxifen treatment reduces survival
- 01/12/15
- Early birth control pill use is linked to recurrence of premenopausal breast cancer
- 11/30/13
- Vitamin C can reduce the effectiveness of tamoxifen treatment
- 09/08/13
- Not completing anti-estrogen treatment linked to sharply higher risk of recurrence
- 07/31/13
- Resveratrol enhances the treatment effects of tamoxifen in ER+ breast cancer
- 05/21/13
- Reduction in breast density from tamoxifen treatment is linked to favorable prognosis
- 04/30/13
- Unpleasant side effects of anti-estrogens can indicate treatment is working
- 12/31/12
- Treatment with Femara after tamoxifen can worsen cholesterol profile
- 12/09/12
- Continuing tamoxifen treatment for 10 years helps prevent late recurrence
- 06/09/11
- Patients with ER-/PR+ breast cancer benefit from endocrine therapy
Studies
-
Intratumoural Cytochrome P450 Expression in Breast Cancer: Impact on Standard of Care Treatment and New Efforts to Develop Tumour-Selective Therapies
Cite
Sneha S, Baker SC, Green A, Storr S, Aiyappa R, Martin S, et al. Intratumoural Cytochrome P450 Expression in Breast Cancer: Impact on Standard of Care Treatment and New Efforts to Develop Tumour-Selective Therapies. Biomedicines. MDPI AG; 2021; 9:290 10.3390/biomedicines9030290